Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10501515 Hepcidin analogues and uses thereof

Patent 10501515 was granted and assigned to Protagonist Therapeutics on December, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Protagonist Therapeutics

0

Current Assignee

Protagonist Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Anne Pernille Tofteng Shelton0

Praveen Madala0

Simone Vink0

Brian Troy Frederick0

Gregory Thomas Bourne0

Jacob Ulrik Fog0

Mark Leslie Smythe0

Date of Patent

December 10, 2019

0

Patent Application Number

162894510

Date Filed

February 28, 2019

0

Patent Citations

US Patent 10059744 α4β7 thioether peptide dimer antagonists

0

US Patent 10301371 Cyclic monomer and dimer peptides having integrin antagonist activity

US Patent 10023614 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

US Patent 10030061 Hepcidin analogues and uses thereof

0

US Patent 10035824 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

US Patent 10196424 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

Patent Citations Received

US Patent 12018057 Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

0

US Patent 10729676 Opioid agonist peptides and uses thereof

US Patent 10787490 Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

0

US Patent 10941183 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

US Patent 11041000 Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

US Patent 11753443 Conjugated hepcidin mimetics

US Patent 11840581 α4β7 thioether peptide dimer antagonists

0

US Patent 11884748 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

0

...

Patent Primary Examiner

0

Patent abstract

The present invention relates, inter alia, to certain hepcidin peptide analogues, including peptides and dimers thereof, and to the use of the peptides and peptide dimers in the treatment and/or prevention of a variety of diseases, conditions or disorders, including treatment and/or prevention of iron overload diseases, which include hereditary hemochromatosis and iron-loading anemias, and other conditions and disorders described herein.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10501515 Hepcidin analogues and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool